Creteil, France

Michaël Rivard

This inventor holds 1 USPTO granted patent and 3 EPO patents. Top assignees: Centre National De La Recherche Scientifique, Université Paris Est Creteil Val De Marne. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michaël Rivard. Retrieved from https://idiyas.com/inventor/michaël-rivard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michaël Rivard: Innovator in Neurodegenerative Disease Research

Introduction

Michaël Rivard is a notable inventor based in Créteil, France. He has made significant contributions to the field of neurodegenerative diseases, particularly through his innovative research and patent.

Latest Patents

Michaël Rivard holds a patent titled "Chemical model of a neurodegenerative disease, method for preparation and uses of same." This invention focuses on the use of pyridinium furosemide or its derivatives in creating a chemical model for neurodegenerative diseases, with a preference for Parkinson's disease. The patent also outlines the uses of this model, especially in screening tests for identifying potential drug candidates.

Career Highlights

Throughout his career, Michaël has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and Université Paris Est Créteil Val de Marne. His work in these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

Michaël has collaborated with notable colleagues, including Thierry Martens and Céline Laurencé. Their joint efforts have furthered the understanding and research in the field of neurodegenerative diseases.

Conclusion

Michaël Rivard's innovative work and patent in the realm of neurodegenerative diseases highlight his commitment to advancing medical research. His contributions are significant in the ongoing quest to understand and treat conditions like Parkinson's disease.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…